Standard NR NR 7 (8.5%) 6 (7%) NR NR 6% requiring 3 (3.7%) 3.8% AVR (including reexploration TIA) Mean blood tx (n = 82) 2.5U Santarpino et al Perceval 8.4 2% 3 (6%) NR 0 RI 2 (4%) Mean blood tx 2 NR (2013)() S (PV leak 1/4) (4%) 1.1U* (n = 50) Standard 10 4% 4 (8%) NR 1 2.3U 3 NR RI 3 (6%) AVR (PV leak 1/4) (2%) (6%) (n = 50) Santarpino et al Perceval 13.3 0 4 (10.8%) 2 (5.4%) NR 0 NR 0 Mean (2013)() S 19mo:d (at least mild AR) 2.7%* (n = 37) TAVI 14.2 13.5% 1 (2.7%) 2 (5.4%) NR 2 (5.4%) NR 3 (8.1%) Mean 19mo:d (n = 37) (at least mild AR) 13.5%* Shrestha et al Perceval 8% NR NR NR NR 2 major bleedb 0 5 (2013)() S (n = 50) (4%) 15.9 (Minor; grade 1) (13%) Standard 12.7 2% NR NR NR NR 2 major bleedb 3 10 AVR (Minor: grade 1) (2.9%) (4.3%) (16%) (n = 70) Doss et al (2012)() 3f Enable 9 0 0 0 NR NR NR 3 NR (n = 27) (Mod/major) (11%)
Standard AVR (n = 82) NR NR 7 (8.5%) 6 (7%) (including TIA) NR NR 6% requiring reexploration Mean blood tx 2.5U 3 (3.7%) 3.8% Santarpino et al (2013)() Perceval S (n = 50) 8.4 2% (PV leak 1/4) 3 (6%) NR 0 RI 2 (4%) Mean blood tx 1.1U* 2 (4%) NR Standard AVR (n = 50) 10 4% (PV leak 1/4) 4 (8%) NR 1 (2%) RI 3 (6%) 2.3U 3 (6%) NR Santarpino et al (2013)() Perceval S (n = 37) 13.3 0 (at least mild AR) 4 (10.8%) 2 (5.4%) NR 0 NR 0 Mean 19mo:d 2.7%* TAVI (n = 37) 14.2 13.5% (at least mild AR) 1 (2.7%) 2 (5.4%) NR 2 (5.4%) NR 3 (8.1%) Mean 19mo:d 13.5%* Shrestha et al (2013)() Perceval S (n = 50) 15.9 8% (Minor; grade 1) NR NR NR NR 2 major bleedb (4%) 0 5 (13%) Standard AVR (n = 70) 12.7 2% (Minor: grade 1) NR NR NR NR 2 major bleedb (2.9%) 3 (4.3%) 10 (16%) Doss et al (2012)() 3f Enable (n = 27) 9 0 (Mod/major) 0 0 NR NR NR 3 (11%) NR
sutureless-aortic-valve-replacement-tier3-assessment.docx